Trial Details
COMPLETEDBasic Information
| Clinical ID | c2909 |
|---|---|
| Identifier | NCT02798991 |
| Trial Title | A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: GSK3179106|DRUG: Matched Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | South Australia |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2016-06 |
|---|---|
| Primary Completion Date | 2016-11 |
| Completion Date | 2016-11 |